Bio-Rad Laboratories Inc
Затворен
СекторЗдравеопазване
278.8 2.85
Преглед
Промяна на цената на акция
24 ч
Минимум
269.92
Максимум
283.35
Приходи | -731M -11M |
|---|---|
Продажби | -101M 592M |
P/E Средно за сектора | 46.696 50.958 |
EPS | 1.89 |
Марж на печалбата | -1.858 |
Служители | 7,450 |
EBITDA | -751M -637M |
Препоръки | Неутрален |
|---|---|
12-месечна прогноза | +11.44% upside |
Следващи печалби | 30.07.2026 г. |
|---|
Пазарна капитализация | -235M 7.5B |
|---|---|
Предишно отваряне | 275.95 |
Предишно затваряне | 278.8 |
Настроения в новините
By Acuity
50%
50%
143 / 342 Класиране в Healthcare
Bio-Rad Laboratories Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.